Synaptic autoimmunity and the Salk factor.
Solimena
M
M
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
De Camilli
P
P
D000818:Animals; D001323:Autoantibodies / Q000009:adverse effects / Q000276:immunology*; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology*; D001812:Blood-Brain Barrier / Q000276:immunology; D002352:Carrier Proteins / Q000378:metabolism; D002648:Child; D004660:Encephalitis / Q000209:etiology / Q000276:immunology*; D005260:Female; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D051938:Munc18 Proteins; D009157:Myasthenia Gravis / Q000209:etiology / Q000276:immunology*; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D009474:Neurons / Q000276:immunology / Q000378:metabolism; D020362:Paraneoplastic Cerebellar Degeneration / Q000276:immunology; D011817:Rabbits; D051381:Rats; D018091:Receptors, AMPA / Q000276:immunology / Q000378:metabolism; D013569:Synapses / Q000276:immunology / Q000378:metabolism; D033921:Vesicular Transport Proteins
D001323:Autoantibodies; D002352:Carrier Proteins; D008565:Membrane Proteins; D051938:Munc18 Proteins; D009419:Nerve Tissue Proteins; D018091:Receptors, AMPA; D033921:Vesicular Transport Proteins; C073441:gephyrin; C104723:glutamate receptor ionotropic, AMPA 3